HAL (France)open access
Multinational cost-utility analysis of panel-based pharmacogenetics-guided treatment of patients enrolled in the U-PGx PREPARE study
Cost-utility analysis, Economic evaluation, 0, Quality of life, Pharmacogenetic-guided treatment, Preemptive testing, 1, Personalized medicine
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 153541
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.